Your Messages Inbox
Your Article Summary
See Latest ArticlesBoston Scientific Announces Japanese Approval for TAXUS Liberte Drug-Eluting Stent System
Boston Scientific, 01/29/09
Boston Scientific Corporation announced that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its TAXUS Liberte Paclitaxel-Eluting Coronary Stent System. The Company plans to launch the product as soon as reimbursement approval is granted, which is expected in the coming weeks.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor